Neurodevelopment Outcome
7
3
4
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
14%
1 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (7)
Implementation Outcomes and Cost-effectiveness of Developmental Monitoring for Children Exposed to HIV
Impact of Hospital to Home: Optimizing Preterm Infant Environment for Surgical Neonates and Their Parents (H-HOPE)
The MOM-CARE Trial : Evaluating Antenatal and Postnatal MMSPlus for Improved Infant Birth and Growth Outcomes
Turkish Version of the BRIEF-Hammersmith Infant Neurological Examination (HINE)
Maternal Risk, Fetal-Neonatal Brain Connectivity, and Early Neurodevelopment: A Longitudinal Observational Study
Gut Microbiota Diversity: Wrong Message in Autism, Wrong Architecture in Formation
The Premature Gut Microbiome and the Influence on Neonatal Immunity, Brain Development and White Matter Injury